AFP News: With EPS Growth And More, AFT Pharmaceuticals (NZSE:AFT) Makes An Interesting Case - 29th Dec 2022, 8:49am

[annb0t]

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. Loss-making companies are always racing against time to reach financial sustainability, so investors in these companies may be taking on more risk than they should.

If ...

>>> Read more: With EPS Growth And More, AFT Pharmaceuticals (NZSE:AFT) Makes An Interesting Case